Hongyan Zhang, Gang Wang, Jingping Zhao, Shiping Xie, Xiufeng Xu, Jianguo Shi, Hehuang Deng, Keqing Li, Chengge Gao, Xiaoping Wang, Douglas Vanderburg, Sharon Pan, Haiyun Tang, Liang Shu, Onur N Karayal
Intramuscular (IM) antipsychotics are preferred for efficient control of agitation symptoms. Previous studies have demonstrated that IM ziprasidone is efficacious and safe for treatment of agitation in schizophrenia. However, clinicians now recognize that racial differences may contribute to altered therapeutic response and tolerability. This study compared the efficacy and tolerability of IM ziprasidone versus IM haloperidol for the management of agitation in Chinese subjects with schizophrenia. Subjects with acute schizophrenia were randomized to either ziprasidone (n = 189, 10 to 20 mg as required up to a maximum of 40 mg/d) or haloperidol (n = 187, 5 mg every 4 to 8 hours to a maximum of 20 mg/d) for 3 days...
April 2013: Journal of Clinical Psychopharmacology